Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Vickers Vantage Corp I (NQ: VCKA )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 10, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vickers Vantage Corp I

Sorrento Therapeutics (SRNE) Pops on FDA Fast Track Designation
Sorrento Therapeutics (SRNE) stock is getting a boost on Wednesday after the FDA granted it fast-track designation for SP-103. 
Via InvestorPlace
The Week In SPAC News: Digital World Under Pressure As Truth Social Rank Slides
In SPAC news this week, Digital World Acquisition was in the spotlight after Truth Social dropped out of the App Store's top 125. Meanwhile, Bridgetown 2 shareholders approved the previously announced... 
Via Talk Markets
Sorrento's Pain Company Reveals Final Results For SP-102 Data For Sciatica Pain Management
Sorrento Therapeutics Inc's (NASDAQ: SRNE) subsidiary Scilex Holding Company has announced final results from its SP-102 Phase 3 Pivotal Trial C.L.E.A.R. Program.  SP-102 (Semdexa) has received Fast... 
Via Benzinga
Vickers Venture SPAC To Merge With Sorrento Therapeutics' Pain-Focused Subsidiary
Vickers Venture Partners' special purpose acquisition company Vickers Vantage Corp I (NASDAQ: VCKA) will merge with Scilex Holding Company, focused on developing and commercializing non-opioid... 
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.